glutamine and gw 501516

glutamine has been researched along with gw 501516 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, J; Gou, Q; Hou, Y; Jin, J; Liu, Q; Shi, J	1

Other Studies

1 other study(ies) available for glutamine and gw 501516

Article	Year
Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells. European journal of pharmacology, 2019, Aug-15, Volume: 857 Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glutamine; Humans; Metformin; Mice; Minor Histocompatibility Antigens; PPAR delta; Thiazoles; Transcription, Genetic; Xenograft Model Antitumor Assays	2019

Article

Year

Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.

European journal of pharmacology, 2019, Aug-15, Volume: 857

Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glutamine; Humans; Metformin; Mice; Minor Histocompatibility Antigens; PPAR delta; Thiazoles; Transcription, Genetic; Xenograft Model Antitumor Assays

2019